Organon Launches U.S. Grant Programs and Listening Tour as Part of “Her Plan Is Her Power,” Reaching High-Need Communities To Help Reduce Unplanned Pregnancies
Today, Organon (NYSE: OGN), a global healthcare company with a focus on women’s health, embarks on the next phase of programming for “Her Plan is Her Power,” to improve access and outcomes related to unplanned pregnancy in the U.S.
Organon Announces Formal Commitment to FP2030 To Help Prevent 120 Million Unintended Pregnancies in Low- and Middle-Income Countries Around the World
Organon announces company’s formal commitment to FP2030 at International Conference on Family Planning in Pattaya City, Thailand